Guided exploration of genomic risk for gray matter abnormalities in schizophrenia using parallel independent component analysis with reference

NeuroImage

Volumn 83, Issue , 2013, Pages 384-396

  Chen, Jiayu ^a,b   Calhoun, Vince D ^a,b,c,d,e   Pearlson, Godfrey D ^d,e   Perrone Bizzozero, Nora ^c   Sui, Jing ^b   Turner, Jessica A ^b   Bustillo, Juan R ^c   Ehrlich, Stefan ^f,g   Sponheim, Scott R ^h,i   Cañive, José M ^c,j   Ho, Beng Choon ^k   Liu, Jingyu ^a,b  

^a MSC01 1070   (United States)

^b MIND RESEARCH NETWORK   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d INSTITUTE OF LIVING   (United States)

^e YALE UNIVERSITY   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^h Minneapolis Veterans Affairs Health Care System   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

^j NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^k UNIVERSITY OF IOWA   (United States)

more..

Author keywords

Multivariate; Parallel ICA with reference; Schizophrenia; Semi blind; SMRI; SNP

Indexed keywords

ADULT; ANK3 GENE; ARTICLE; BRAIN MALFORMATION; CONTROLLED STUDY; DIMENSIONAL MEASUREMENT ACCURACY; EFFECT SIZE; FEMALE; GENE; GENETIC CORRELATION; GENETIC LOAD; GENETIC RISK; GRAY MATTER; GRAY MATTER ABNORMALITY; HUMAN; INDEPENDENT COMPONENT ANALYSIS; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARALLEL INDEPENDENT COMPONENT ANALYSIS WITH REFERENCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SIMULATION; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPORAL LOBE; VALIDATION STUDY; ADOLESCENT; BRAIN; CHROMOSOMAL MAPPING; FEASIBILITY STUDY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; MULTIVARIATE ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN; CHROMOSOME MAPPING; DATA INTERPRETATION, STATISTICAL; FEASIBILITY STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; GRAY MATTER; HUMANS; MALE; MULTIVARIATE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84880958277     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2013.05.073     Document Type: Article

References (98)

1. Abrahams B.S., Tentler D., Perederiy J.V., Oldham M.C., Coppola G., Geschwind D.H. Genome-wide analyses of human Perisylvian cerebral cortical patterning. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:17849-17854.
2. Albert K.A., Hemmings H.C., Adamo A.I.B., Potkin S.G., Akbarian S., Sandman C.A., et al. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Arch. Gen. Psychiatry 2002, 59:705-712.
3. Aleman A., Hijman R., de Haan E.H., Kahn R.S. Memory impairment in schizophrenia: a meta-analysis. Am. J. Psychiatry 1999, 156:1358-1366.
4. Amari S. Natural gradient works efficiently in learning. Neural Comput. 1998, 10:251-276.
5. Amari S., Cichocki A., Yang H.H. A new learning algorithm for blind signal separation. Advances in Neural Information Processing Systems 1996, 752-763. MIT Press, Cambridge, MA. D.S. Touretzky, M.C. Mozer, M.E. Hasselmo (Eds.).
6. Anderson C.A., Pettersson F.H., Clarke G.M., Cardon L.R., Morris A.P., Zondervan K.T. Data quality control in genetic case-control association studies. Nat. Protoc. 2010, 5:1564-1573.
7. Andreasen N.C., Flaum M., Arndt S. The Comprehensive Assessment of Symptoms and History (Cash) - an instrument for assessing diagnosis and psychopathology. Arch. Gen. Psychiatry 1992, 49:615-623.
8. Ashburner J., Friston K.J. Unified segmentation. Neuroimage 2005, 26:839-851.
9. Bakker S.C., van der Meulen E.M., Buitelaar J.K., Sandkuijl L.A., Pauls D.L., Monsuur A.J., et al. A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am. J. Hum. Genet. 2003, 72:1251-1260.
10. Bell A.J., Sejnowski T.J. An Information maximization approach to blind separation and blind deconvolution. Neural Comput. 1995, 7:1129-1159.
11. Blumenfeld R.S., Parks C.M., Yonelinas A.P., Ranganath C. Putting the pieces together: the role of dorsolateral prefrontal cortex in relational memory encoding. J. Cogn. Neurosci. 2011, 23:257-265.
12. Brans R.G., van Haren N.E., van Baal G.C., Schnack H.G., Kahn R.S., Hulshoff Pol H.E. Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia. Arch. Gen. Psychiatry 2008, 65:1259-1268.
13. Buckner R.L., Kelley W.M., Petersen S.E. Frontal cortex contributes to human memory formation. Nat. Neurosci. 1999, 2:311-314.
14. Calhoun V.D., Adali T., Giuliani N.R., Pekar J.J., Kiehl K.A., Pearlson G.D. Method for multimodal analysis of independent source differences in schizophrenia: combining gray matter structural and auditory oddball functional data. Hum. Brain Mapp. 2006, 27:47-62.
15. Cannon T.D., Thompson P.M., van Erp T.G.M., Toga A.W., Poutanen V.P., Huttunen M., et al. Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:3228-3233.
16. Chavarria-Siles I., Rijpkema M., Lips E., Arias-Vasquez A., Verhage M., Franke B., et al. Genes encoding heterotrimeric g-proteins are associated with gray matter volume variations in the medial frontal cortex. Cereb. Cortex 2013, 23:1025-1030.
17. Chen J., Calhoun V.D., Liu J. ICA order selection based on consistency: application to genotype data. 34th Annual International Conference of the IEEE Engineering in Medicine and Biology Society 2012, 360-363.
18. Collingridge G.L., Peineau S., Howland J.G., Wang Y.T. Long-term depression in the CNS. Nat. Rev. Neurosci. 2010, 11:459-473.
19. Cooke S.F., Bliss T.V. Plasticity in the human central nervous system. Brain 2006, 129:1659-1673.
20. Coyle J.T. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell. Mol. Neurobiol. 2006, 26:365-384.
21. Davidson R.J., Pizzagalli D., Nitschke J.B., Putnam K. Depression: perspectives from affective neuroscience. Annu. Rev. Psychol. 2002, 53:545-574.
22. Derks E.M., Vorstman J.A., Ripke S., Kahn R.S., Ophoff R.A. Investigation of the genetic association between quantitative measures of psychosis and schizophrenia: a polygenic risk score analysis. PLoS One 2012, 7:e37852.
23. Deutsch S.I., Rosse R.B., Schwartz B.L., Mastropaolo J. A revised excitotoxic hypothesis of schizophrenia: therapeutic implications. Clin. Neuropharmacol. 2001, 24:43-49.
24. Duan J.B., Sanders A.R., Gejman P.V. Genome-wide approaches to schizophrenia. Brain Res. Bull. 2010, 83:93-102.
25. Edelman G.M. Cell adhesion molecules. Science 1983, 219:450-457.
26. Egan M.F., Straub R.E., Goldberg T.E., Yakub I., Callicott J.H., Hariri A.R., et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:12604-12609.
27. Erhardt E.B., Allen E.A., Wei Y., Eichele T., Calhoun V.D. SimTB, a simulation toolbox for fMRI data under a model of spatiotemporal separability. Neuroimage 2012, 59:4160-4167.
28. Ferreira M.A., O'Donovan M.C., Meng Y.A., Jones I.R., Ruderfer D.M., Jones L., et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat. Genet. 2008, 40:1056-1058.
29. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., Benjamin L.S. Structured Clinical Interview for DSM-IV Axis II Personality Disorders, (SCID-II) 1997, American Psychiatric Press, Washington, DC. 4th ed.
30. Fischl B., Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:11050-11055.
31. Frantseva M.V., Fitzgerald P.B., Chen R., Moller B., Daigle M., Daskalakis Z.J. Evidence for impaired long-term potentiation in schizophrenia and its relationship to motor skill learning. Cereb. Cortex 2008, 18:990-996.
32. Gardner D.M., Murphy A.L., O'Donnell H., Centorrino F., Baldessarini R.J. International consensus study of antipsychotic dosing. Am. J. Psychiatry 2010, 167:686-693.
33. Girirajan S., Brkanac Z., Coe B.P., Baker C., Vives L., Vu T.H., et al. Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet. 2011, 7:e1002334.
34. Glahn D.C., Ragland J.D., Abramoff A., Barrett J., Laird A.R., Bearden C.E., et al. Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum. Brain Mapp. 2005, 25:60-69.
35. Glahn D.C., Laird A.R., Ellison-Wright I., Thelen S.M., Robinson J.L., Lancaster J.L., et al. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol. Psychiatry 2008, 64:774-781.
36. Gottesman I.I., Shields J. A polygenic theory of schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 1967, 58:199-205.
37. Guidotti A., Di-Giorgi-Gerevini V. Decrease in reelin and glutamic acid decarboxylase(67) (GAD(67)) expression in schizophrenia and bipolar disorder (vol 57, pg 1061, 2000). Arch. Gen. Psychiatry 2002, 59:12-12.
38. Gur R.E., Nimgaonkar V.L., Almasy L., Calkins M.E., Ragland J.D., Pogue-Geile M.F., et al. Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. Am. J. Psychiatry 2007, 164:813-819.
39. Harrison P.J. The neuropathology of schizophrenia - a critical review of the data and their interpretation. Brain 1999, 122:593-624.
40. Hennekens C.H., Hennekens A.R., Hollar D., Casey D.E. Schizophrenia and increased risks of cardiovascular disease. Am. Heart J. 2005, 150:1115-1121.
41. Hoe H.S., Lee K.J., Carney R.S., Lee J., Markova A., Lee J.Y., et al. Interaction of reelin with amyloid precursor protein promotes neurite outgrowth. J. Neurosci. 2009, 29:7459-7473.
42. Howes O.D., Kapur S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr. Bull. 2009, 35:549-562.
43. Huang D.W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37:1-13.
44. Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
45. Jay T.M. Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Prog. Neurobiol. 2003, 69:375-390.
46. Jeste D.V., Gladsjo J.A., Lindamer L.A., Lacro J.P. Medical comorbidity in schizophrenia. Schizophr. Bull. 1996, 22:413-430.
47. Klamroth K., Tind J. Constrained optimization using multiple objective programming. J. Glob. Optim. 2007, 37:325-355.
48. Krystal J.H., Mathew S.J., D'Souza D.C., Garakani A., Gunduz-Bruce H., Charney D.S. Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists. CNS Drugs 2010, 24:669-693.
49. Kuperberg G.R., Broome M.R., McGuire P.K., David A.S., Eddy M., Ozawa F., et al. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch. Gen. Psychiatry 2003, 60:878-888.
50. Lambert S., Davis J.Q., Bennett V. Morphogenesis of the node of Ranvier: co-clusters of ankyrin and ankyrin-binding integral proteins define early developmental intermediates. J. Neurosci. 1997, 17:7025-7036.
51. Lidow M.S. Calcium signaling dysfunction in schizophrenia: a unifying approach. Brain Res. Rev. 2003, 43:70-84.
52. Lightbody A.A., Reiss A.L. Gene, brain, and behavior relationships in fragile X syndrome: evidence from neuroimaging studies. Dev. Disabil. Res. Rev. 2009, 15:343-352.
53. Lin Q.H., Liu J.Y., Zheng Y.R., Liang H.L., Calhoun V.D. Semiblind spatial ICA of fMRI using spatial constraints. Hum. Brain Mapp. 2010, 31:1076-1088.
54. Linden D.J., Connor J.A. Long-term synaptic depression. Annu. Rev. Neurosci. 1995, 18:319-357.
55. Liu J., Pearlson G., Windemuth A., Ruano G., Perrone-Bizzozero N.I., Calhoun V. Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA. Hum. Brain Mapp. 2009, 30:241-255.
56. Liu J., Ghassemi M.M., Michael A.M., Boutte D., Wells W., Perrone-Bizzozero N., et al. An ICA with reference approach in identification of genetic variation and associated brain networks. Front. Hum. Neurosci. 2012, 6:21.
57. Manoach D.S. Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings. Biol. Psychiatry 2002, 51:104s-104s.
58. Mattson M.P. Calcium as sculptor and destroyer of neural circuitry. Exp. Gerontol. 1992, 27:29-49.
59. Minzenberg M.J., Laird A.R., Thelen S., Carter C.S., Glahn D.C. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch. Gen. Psychiatry 2009, 66:811-822.
60. Murray L.J., Ranganath C. The dorsolateral prefrontal cortex contributes to successful relational memory encoding. J. Neurosci. 2007, 27:5515-5522.
61. Narr K.L., Bilder R.M., Toga A.W., Woods R.P., Rex D.E., Szeszko P.R., et al. Mapping cortical thickness and gray matter concentration in first episode schizophrenia. Cereb. Cortex 2005, 15:708-719.
62. Oliphant A., Barker D.L., Stuelpnagel J.R., Chee M.S. Bead Array technology: enabling an accurate, cost-effective approach to high-throughput genotyping. Biotechniques 2002, 32(Suppl. 56-58):60-61.
63. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 1995, 52:998-1007.
64. Paulsen J.S., Heaton R.K., Sadek J.R., Perry W., Delis D.C., Braff D., et al. The nature of learning and memory impairments in schizophrenia. J. Int. Neuropsychol. Soc. 1995, 1:88-89.
65. Pizzagalli D.A. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 2011, 36:183-206.
66. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 2006, 38:904-909.
67. Pujadas L., Gruart A., Bosch C., Delgado L., Teixeira C.M., Rossi D., et al. Reelin regulates postnatal neurogenesis and enhances spine hypertrophy and long-term potentiation. J. Neurosci. 2010, 30:4636-4649.
68. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
69. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
70. Rasch B., Papassotiropoulos A., de Quervain D.F. Imaging genetics of cognitive functions: focus on episodic memory. Neuroimage 2010, 53:870-877.
71. Ripke S., Sanders A.R., Kendler K.S., Levinson D.F., Sklar P., Holmans P.A., et al. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 43:969-976.
72. Rissanen J. Modeling by shortest data description. Automatica 1978, 14:465-471.
73. Rose E.J., Donohoe G. Brain vs behavior: an effect size comparison of neuroimaging and cognitive studies of genetic risk for schizophrenia. Schizophr. Bull. 2013, 39:518-526.
74. Rutishauser U., Jessell T.M. Cell adhesion molecules in vertebrate neural development. Physiol. Rev. 1988, 68:819-857.
75. Sastry P.S., Rao K.S. Apoptosis and the nervous system. J. Neurochem. 2000, 74:1-20.
76. Scott L.J., Muglia P., Kong X.Q., Guan W., Flickinger M., Upmanyu R., et al. Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7501-7506.
77. Segall J.M., Allen E.A., Jung R.E., Erhardt E.B., Arja S.K., Kiehl K., et al. Correspondence between structure and function in the human brain at rest. Front. Neuroinformatics 2012, 6:10.
78. Shen R., Fan J.B., Campbell D., Chang W.H., Chen J., Doucet D., et al. High-throughput SNP genotyping on universal bead arrays. Mutat. Res. Fundam. Mol. Mech. Mutagen. 2005, 573:70-82.
79. Shenton M.E., Dickey C.C., Frumin M., McCarley R.W. A review of MRI findings in schizophrenia. Schizophr. Res. 2001, 49:1-52.
80. Spalice A., Parisi P., Nicita F., Pizzardi G., Del Balzo F., Iannetti P. Neuronal migration disorders: clinical, neuroradiologic and genetics aspects. Acta Paediatr. 2009, 98:421-433.
81. Stone J.M., Day F., Tsagaraki H., Valli I., McLean M.A., Lythgoe D.J., et al. Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume. Biol. Psychiatry 2009, 66:533-539.
82. Stranger B.E., Stahl E.A., Raj T. Progress and promise of genome-wide association studies for human complex trait genetics. Genetics 2011, 187:367-383.
83. Strauss K.A., Puffenberger E.G., Huentelman M.J., Gottlieb S., Dobrin S.E., Parod J.M., et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N. Engl. J. Med. 2006, 354:1370-1377.
84. Svenningsson P., Nishi A., Fisone G., Girault J.A., Nairn A.C., Greengard P. DARPP-32: an integrator of neurotransmission. Annu. Rev. Pharmacol. Toxicol. 2004, 44:269-296.
85. Thompson P.M., Cannon T.D., Narr K.L., van Erp T., Poutanen V.P., Huttunen M., et al. Genetic influences on brain structure. Nat. Neurosci. 2001, 4:1253-1258.
86. Toescu E.C. Apoptosis and cell death in neuronal cells: where does Ca2+ fit in?. Cell Calcium 1998, 24:387-403.
87. Turner J.A., Smyth P., Macciardi F., Fallon J.H., Kennedy J.L., Potkin S.G. Imaging phenotypes and genotypes in schizophrenia. Neuroinformatics 2006, 4:21-49.
88. Turner J.A., Calhoun V.D., Michael A., van Erp T.G., Ehrlich S., Segall J.M., et al. Heritability of multivariate gray matter measures in schizophrenia. Twin Res. Hum. Genet. 2012, 15:324-335.
89. van Haren N.E., Hulshoff Pol H.E., Schnack H.G., Cahn W., Mandl R.C., Collins D.L., et al. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology 2007, 32:2057-2066.
90. Vernes S.C., Newbury D.F., Abrahams B.S., Winchester L., Nicod J., Groszer M., et al. A functional genetic link between distinct developmental language disorders. N. Engl. J. Med. 2008, 359:2337-2345.
91. Vounou M., Nichols T.E., Montana G., Initia A.D.N. Discovering genetic associations with high-dimensional neuroimaging phenotypes: a sparse reduced-rank regression approach. Neuroimage 2010, 53:1147-1159.
92. Wahlbeck K., Ahokas A., Nikkila H., Miettinen K., Rimon R. Cerebrospinal fluid angiotensin-converting enzyme (ACE) correlates with length of illness in schizophrenia. Schizophr. Res. 2000, 41:335-340.
93. Wang K., Abbott D. A principal components regression approach to multilocus genetic association studies. Genet. Epidemiol. 2008, 32:108-118.
94. Wedenoja J., Loukola A., Tuulio-Henriksson A., Paunio T., Ekelund J., Silander K., et al. Replication of linkage on chromosome 7q22 and association of the regional reelin gene with working memory in schizophrenia families. Mol. Psychiatry 2008, 13:673-684.
95. Weng L., Macciardi F., Subramanian A., Guffanti G., Potkin S.G., Yu Z., et al. SNP-based pathway enrichment analysis for genome-wide association studies. BMC Bioinformatics 2011, 12:99.
96. Xu L., Liu J., Adali T., Calhoun V.D. Source based morphometry using structural MRI phase images to identify sources of gray matter and white matter relative differences in schizophrenia versus controls. International Conference on Acoustics, Speech, and Signal Processing (ICASSP), Las Vegas, NV 2008.
97. Xu B., Woodroffe A., Rodriguez-Murillo L., Roos J.L., van Rensburg E.J., Abecasis G.R., et al. Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:16746-16751.
98. Zhou D., Lambert S., Malen P.L., Carpenter S., Boland L.M., Bennett V. AnkyrinG is required for clustering of voltage-gated Na channels at axon initial segments and for normal action potential firing. J. Cell Biol. 1998, 143:1295-1304.